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ABSTRACT
GTP hydrolysis catalyzed in the ribosome by a
complex of two polypeptide release factors, eRF1
and eRF3, is required for fast and efficient termina-
tion of translation in eukaryotes. Here, isothermal
titration calorimetry is used for the quantitative
thermodynamiccharacterizationofeRF3interactions
with guanine nucleotides, eRF1 and Mg
21. We show
that (i) eRF3 binds GDP (Kd = 1.9 mM) and this
interaction depends only minimally on the Mg
21
concentration; (ii) GTP binds to eRF3 (Kd = 0.5 mM)
only in the presence of eRF1 and this interaction
depends on the Mg
21 concentration; (iii) GTP dis-
places GDP from the eRF1 eRF3 GDP complex, and
viceversa;(iv)eRF3intheGDP-boundformimproves
its ability to bind eRF1; (v) the eRF1 eRF3 complex
binds GDP as efficiently as free eRF3; (vi) the
eRF1 eRF3 complex is efficiently formed in the
absence of GDP/GTP but requires the presence of
the C-terminus of eRF1 for complex formation. Our
results show that eRF1 mediates GDP/GTP displace-
ment on eRF3. We suggest that after formation of
eRF1 eRF3 GTP Mg
21, this quaternary complex
binds to the ribosomal pretermination complex con-
taining P-site-bound peptidyl-tRNA and the A-site-
bound stop codon. The guanine nucleotide binding
properties of eRF3 and of the eRF3 eRF1 complex
profoundly differ from those of prokaryotic RF3.
INTRODUCTION
Termination of protein synthesis in eukaryotes is governed
by three stop codons, UAA, UAG or UGA, at the ribosomal
A-site and by two translation termination factors, designated
eRF1 (1) and eRF3 (2). eRF1 recognizes all three stop codons
in the decoding center via its N-terminal domain (3–6) in
which the highly conversed YxCxxxF motif plays a pivotal
role in discriminating purine bases in the second and third
stop codon positions (7,8). The major function of eRF1 is
to transfer a signal from the small to the large ribosomal
subunit and to trigger peptidyl-tRNA hydrolysis at the
peptidyl-transferase center [reviewed in (9)]. The key role
in the termination reaction is played by the invariant GGQ
motif located at the tip of the M domain of eRF1 (10–12).
The C-terminal domain is not mandatory for eRF1 function
in vitro in a simpliﬁed model system (13) but in a completely
reconstituted in vitro protein synthesizing machinery it is
essential (14).
eRF3 is a GTPase whose activity depends entirely on the
ribosome and eRF1 (15). Binding of eRF3 to eRF1 as
revealed in vivo and in vitro (2,16,17) is mediated by the
C-terminal domains of both proteins (18–20).
Several hypotheses have been suggested regarding the pos-
sible biological function of eRF3, encoded by an essential
gene [reviewed in (21)]. It is proposed that eRF3 helps
eRF1 bind to the stop codon-charged ribosome similarly to
prokaryotic elongation factor EF-Tu which increases the
afﬁnity of the aminoacyl-tRNA to the A-site programmed
with a sense codon (22). This hypothesis is based on two
observations: (i) eRF3 possesses a signiﬁcant degree of
homology with eEF1A, an analog of prokaryotic EF-Tu
(23,24) and (ii) it stimulates peptidyl-tRNA hydrolysis trig-
gered by eRF1 at low mRNA concentrations (15). In early
studies on translation termination in eukaryotes (25,26), it
was shown that a dimeric RF (in view of later data this was
most likely an eRF1 eRF3 complex) bound to the ribosome
and in the presence of GTP stimulated peptidyl-tRNA hydrol-
ysis coupled with GTP hydrolysis. It has also been suggested
that eRF3 possesses a proofreading function in stop codon
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lated that eRF3 could be a functional analog of RF3 known to
facilitate RF1/RF2 release from the ribosome after peptidyl-
tRNA hydrolysis (28).
The primary structure of yeast eRF3 has been subdivided
into N, M and C regions and it was demonstrated that the
variable N region is not mandatory for the eRF3 function in
translation termination, while the C region which is highly
conserved is functionally essential (23). The structure of the
C-terminal part (positions 196–662) of Schizosaccharomyces
pombe eRF3 was resolved by X-ray analysis (24). In this
sequence truncated of its N-terminus, domain 1 (positions
237–467) binds guanine nucleotides and probably Mg
2+,
and domain 3 (positions 555–662) binds to the C-terminus
of eRF1 as shown earlier (18–20). The function of domain
2 remains unknown.
Mutations of yeast eRF3 that reduce GTPase activity cause
an increase in readthrough efﬁciency in vivo indicating a
decrease in translation termination efﬁciency (27). GTP inﬂu-
ences the interaction of eRF1 with eRF3 at physiological
Mg
2+ concentrations (29). In a completely reconstituted
in vitro protein synthesizing system (14) eRF3 together with
GTP considerably increase the rate of peptidyl-tRNA hydrol-
ysis promoted by eRF1 which proceeds after GTP hydrolysis
within the ribosome. The factors act cooperatively in the ter-
mination reaction and it is likely (14) that eRF3 increases the
afﬁnity of eRF1 for the ribosome as suggested previously (22).
Lack of sufﬁcient information concerning the interaction
between eRF3, eRF1 and guanine nucleotides in vitro ham-
pers deeper understanding of the GTP/GDP cycle involved
in translation termination. For this reason, the aim of the pre-
sent study has been to use isothermal titration calorimetry
(ITC) to follow quantitatively complex formation between
eRF3 and its ligands comparing the thermodynamic parame-
ters of these complexes. The principal advantage of the ITC
approach stems from the fact that it does not require any kind
of modiﬁcations of the interacting molecules under investiga-
tion and experiments are performed at equilibrium avoiding
artifacts caused by possible dissociation of the complex in
non-equilibrium conditions.
We have shown here that eRF3 binds GDP independently
of the presence or absence of eRF1 whereas GTP binds only
to the eRF1 eRF3 complex. We suggest that the quaternary
eRF1 eRF3 GTP Mg
2+ complex binds to the ribosomal
pretermination complex; owing to the action of the ribosomal
GTPase center, the GTPase activity is thus induced which in
turn is followed by peptidyl-tRNA hydrolysis. Based on these
results, we conclude that the biological role of prokaryotic
RF3 and eukaryotic eRF3 is fundamentally different in agree-
ment with earlier conclusions that translation termination
mechanisms in general are profoundly distinct in eukaryotes
and prokaryotes (14).
MATERIALS AND METHODS
Human eRF3 and eRF1 preparations
The human eRF1 [wild-type and truncated eRF1 (amino acids
1–275) without the C domain] and truncated eRF3 (amino
acids 139–637), all of them tagged with a C-terminal hexahis-
tidine, were overproduced in Escherichia coli BL21(DE3) for
eRF1 and C41(DE3) for eRF3. After afﬁnity chromatography
on Ni-NTA agarose (Qiagen) the resulting preparations were
applied on the HiTrap Q HP 16/25 5 ml ion-exchange column
(Amersham Pharmacia Biotech) in 50 mM Tris–HCl
(pH 7.5), 0.1 M KCl, 10 mM b-mercaptoethanol, 0.2 mM
imidazole and 15% glycerol for eRF3 and in 50 mM Tris–
HCl (pH 7.5), 0.2 M KCl, 3 mM DTT, 0.035% Tween-20,
0.15 M imidazole and 10% glycerol for eRF1. The columns
were washed with 0.1 M KCl, 50 mM Tris–HCl (pH 7.5),
10% glycerol and 5 mM b-mercaptoethanol for eRF3 and
with 0.24 M KCl, 50 mM Tris–HCl (pH 8.0) and 0.1 mM
EDTA for eRF1. Peak fractions of eRF3 eluted at 0.21 M
KCl; they were collected and dialyzed against phosphate
[0.1 M KCl, 25 mM potassium phosphate (pH 7.5), 10%
glycerol and 1 mM DTT] or Tris [0.15 M KCl, 50 mM Tris–
HCl (pH 7.5), 10% glycerol and 5 mM b-mercaptoethanol]
buffers and varying concentrations of MgCl2. eRF1 was
eluted with 255 mM KCl, 50 mM Tris–HCl (pH 8.0),
0.1 mM EDTA and dialyzed against either phosphate or
Tris buffers as for eRF3. After dialysis the samples were
used in ITC experiments. If necessary, the samples were con-
centrated by ion-exchange chromatography on HiTrap Q HP
7/25 1 ml column or using centricon UFV4BGC25 tubes
(Millipore). The eRF1 and eRF3 preparations produced single
bands after denaturing gel electrophoresis. The molecular
masses of the proteins (55 and 50 kDa for eRF3 and eRF1,
respectively) corresponded to the values deduced from the
amino acid sequences. The protein concentrations were
determined spectrophotometrically using a molar extinction
coefﬁcient e280 ¼ 39770 M
 1 cm
 1 for eRF3 and e280 ¼
29780M
 1 cm
 1 for eRF1.
Purification of guanine nucleotides
Commercial preparations of GDP and GTP (ICN) were
puriﬁed using a high-performance liquid chromatography
(Gilson) and a Lichrosorb RP-18 column. The purity of the
GDP and GTP preparations estimated by NMR was not
lower than 99%.
Isothermal titration calorimetry
The thermodynamic parameters of eRF3 binding to eRF1,
GDP and GTP were measured using a MicroCal VP-ITC
instrument (MicroCal, Northampton, MA). Experiments
were carried out at 25 C in phosphate (25 mM K2HPO4,
10% glycerol, 1 mM DTT and 0.1 M KCl) or in Tris (50
mM Tris–HCl, 10% glycerol, 5 mM b-mercaptoethanol and
0.15 M KCl) buffers, at pH 7.5. The MgCl2 concentration
varied from 0 to 10 mM. All solutions were degassed under
vacuum for 5 min immediately before measurements. Ali-
quots (10 ml) of ligands were injected from a 296 ml syringe
into the 1.42 ml cell containing the protein solution to
achieve a complete binding isotherm. The protein concentra-
tion in the cell ranged from 6 to 15 mM and ligand concentra-
tion in the syringe ranged from 50 to 300 mM. The heat of
dilution was measured by injecting the ligand into the buffer
solution or by additional injections of ligand after saturation;
the values obtained were subtracted from the heat of the
reaction to obtain the effective heat of binding. The result-
ing titration curves were ﬁtted using the MicroCal Origin
3948 Nucleic Acids Research, 2006, Vol. 34, No. 14software, assuming one set of sites. Afﬁnity constants (Ka)
and enthalpy variations (DH) were determined. Consequently,
the Gibbs energy (DG) and the entropy variations (DS) were
calculated from the relation: DG ¼  RTlnKa ¼ DH   TDS.
The stoichiometry of eRF3 binding to eRF1 and guanine
nucleotides, calculated using ITC data, was below one. At
physiological concentration of Mg
2+ (2.0 mM) the binding
stoichiometry was equal to 0.47 ± 0.15. One eRF3 molecule
binds one eRF1 molecule (17), and bears a single site for
binding to the guanine nucleotide (24); the binding stoichi-
ometry observed shows that the efﬁcient concentration of
eRF3 and/or eRF1 is below 100% (30). This may be caused
by partial inactivation or oligomerization of eRF3 and/or
eRF1 during puriﬁcation or measurements.
When the signal was too low to be measured directly, a dis-
placement titration calorimetry method (31) was applied that
consists in measuring an apparent binding constant (Kapp)
corresponding to the displacement of one ligand by another.
In this case, eRF3 was saturated with ligand L1 (GDP or
GTP) placed into the calorimeter cell and then titrated with
10 ml aliquots of ligand L2 (GTP or GDP). An apparent bind-
ing constant, corresponding to the displacement of L1 by L2,
was determined. Then, knowing the binding constant K1 of
L1, we determined the value of the binding constant K2 of
L2 for eRF3 from the equation K2 ¼ Kapp(1 + K1[L1])
(31,32). All experiments were carried out two to four times.
RESULTS
ITC was used for direct determination of the thermodynamic
parameters for binding of eRF3 and its complexes to eRF1,
GDP and GTP. ITC experiments were performed in phos-
phate or Tris buffers (commonly used in biochemical experi-
ments with translation factors) in order to examine the
contribution of the heat of buffer ionization to complex
formation. Table 1 presents the experiments performed in
phosphate buffer. The data in Tris buffer were in most
cases similar to those in phosphate buffer. Whenever the
results depend on the buffer composition, this is mentioned
in the text.
eRF3 binds GDP but not GTP
A typical set of ITC data for GDP binding to eRF3 in phos-
phate buffer in the presence or absence of Mg
2+ is shown in
Figure 1A–C. The upper panel presents the raw calorimetric
data for the titration of the protein by ligand and the lower
panel presents the binding isotherms. In both phosphate and
Tris buffers elevation of Mg
2+ concentration caused a slight
decrease in GDP afﬁnity for eRF3 (Table 1). Indeed, in the
absence of Mg
2+, the dissociation constant Kd is equal to
1.1 mM, while at physiological (2 mM) Mg
2+ it increases
1.7-fold in both buffers. As is clear from the thermodynamic
parameters (Table 1), the binding of GDP to eRF3 is
enthalpy-driven. However, at non-physiological (10 mM)
Mg
2+ concentration the enthalpic contribution to overall
free energy diminishes while the enthropic contribution
increases. Thus, despite the fact that Mg
2+ is not essential
for GDP binding to eRF3, at high concentrations it dramati-
cally changes the thermodynamic proﬁle of the interaction
(Table 1 and Figure 1). We observed no Mg
2+ binding to
eRF3. In contrast to GDP binding, we failed to reveal any
measurable GTP binding to eRF3 in either phosphate or
Tris in the absence and presence of 2 mM Mg
2+. It should
be noted that binding constants below 10
3 M
 1 cannot be
measured by the ITC method.
Energetics of complex formation
between eRF3 and eRF1
As mentioned above, eRF3 and eRF1 form an equimolar
complex in vitro but the binding constant and thermodyn-
amic parameters of this interaction are unknown. Complex
formation between eRF1 and eRF3 is an enthalpy-favorable
process (Table 1). In both phosphate and Tris buffers at
2m MM g
2+ the association constant (Ka)i s 10
6 M
 1.
This value decreases 2-fold in the absence of Mg
2+.I n
Tris buffer the alteration in the observed enthalpy
[DHobs(Tris) ¼  19.2 kcal/mol] is signiﬁcantly higher than
in phosphate buffer [DHobs(Pi) ¼  8.2 kcal/mol]. This dif-
ference is caused by changes in the protonation state of pro-
tein amino acid residues upon binding, because the enthalpy
Table 1. Thermodynamic parameters of eRF3 binding to eRF1, GDP and GTP at 25 C and pH 7.5 determined by ITC
a
Sample Ligand MgCl2 (mM) Ka
b(M
 1) Kd
c (mM) DH
d(kcal/mol) TDS (kcal/mol) DG (kcal/mol)
eRF3 GDP 0 9.1 · 10
5 1.1  9.8  1.7  8.1
eRF3 GDP 2 5.6 · 10
5 1.9  9.2  1.4  7.8
eRF3 GDP 10 3.6 · 10
5 2.8  2.1 5.5  7.6
eRF3 eRF1 0 6.0 · 10
5 1.7  7.4
e  0.5  7.9
eRF3 eRF1 2 1.4 · 10
6 0.7  7.2
e 1.2  8.4
eRF3 GDP eRF1 2 4.9 · 10
6 0.2  3.1
e 6.0  9.1
eRF1 eRF3 GDP 2 5.1 · 10
5 2.0  11.8  4.0  7.8
eRF1 eRF3 GTP 0 3.6 · 10
5 2.8 1.1 8.7  7.6
eRF1 eRF3 GTP 2 2.0 · 10
6 0.5  2.2 6.4  8.6
eRF1 eRF3 GDP
f GTP 2 3.1 · 10
6 0.3  8.9
eRF1 eRF3 GTP
f GDP 2 4.6 · 10
5 2.2  7.7
aAll measurements were performed in phosphate (25 mM K2HPO4, 10% glycerol, 1 mM DTT and 0.1 M KCl) buffer.
bThe standard deviation did not exceed ±20%.
cCalculated as 1/Ka.
dThe standard deviation did not exceed ±8%.
eDH was calculated taking into account the effect of protonation (for details see text).
fThe model of competitive ligand binding was used (Materials and Methods).
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of phosphate buffer (11 kcal/mol versus 1 kcal/mol) (33).
The enthalpy of ionization (DHi) is a unique property of dif-
ferent buffer systems and when protonation accompanies
complex formation, it can be used to determine the number
of interacting protons (30). The DHobs from the titration
experiment at a given pH is thus composed of the heat of
binding and the protonation effect: DHobs ¼ DHb +
(Dn)DHi, where DHb is the true intrinsic heat of binding
and Dn is the number of protons released or taken by the
buffer upon binding.
Since DHobs in phosphate buffer is less exothermic, we sug-
gest that protons are released at the association step. It cannot
be determined whether protons are released from eRF3 or
from eRF1 but the total number of released protons is
determined by the following relation (33):
Dn ¼
DHobsðPiÞ DHobsðTrisÞ
DHiðPiÞ DHiðTrisÞ
‚
where DHi(Pi) is the enthalpy of phosphate buffer ionization
and DHi(Tris) is the enthalpy of Tris buffer ionization. For
eRF1 eRF3 binding Dn ¼  1.1. Hence, association of the
factors is accompanied by proton release from the complex
into solution. This is probably induced by conformational
changes of one or of both factors (17), leading to alteration
of the pK of an amino acid residue in the complex.
In the GDP-bound state, eRF3 binds to eRF1 with 3.5
times higher afﬁnity than does free eRF3 (Table 1). As in
the case of complex formation between eRF3 and eRF1,
when the eRF3 GDP complex binds eRF1 in Tris buffer,
DHobs is much higher ( 13.5 kcal/mol) than in phosphate
buffer ( 4.1 kcal/mol). For the eRF3 GDP association with
eRF1 Dn ¼  0.8, also indicating release of one proton into
the solution.
It is known that C-terminal truncation of eRF1s from ﬁs-
sion yeast and human largely or completely abolishes interac-
tion of eRF1 with eRF3 (13,18,19,34). Human eRF1 deprived
of its C domain loses its ability to bind eRF3 as determined
by ITC experiments (data not shown), in entire agreement
with the above mentioned biochemical observations.
The eRF1 eRF3 complex binds GTP
The eRF1 eRF3 complex binds GDP as efﬁciently as free
eRF3 at 2 mM Mg
2+ and the thermodynamic proﬁle of
GDP binding to the eRF1 eRF3 complex is virtually the
same as to free eRF3 (Table 1). In contrast to free eRF3,
eRF3 complexed with eRF1 acquires the ability to bind
GTP (Table 1). Moreover, the constant of GTP binding to
the eRF1 eRF3 complex is four times higher than that of
GDP binding and is equal to 2 · 10
6 M
 1 at 2.0 mM Mg
2+
(Table 1). In contrast to the enthalply-driven process of
GDP binding to the eRF1 eRF3 complex, GTP binding has
a reduced enthalpic contribution and a larger entropic compo-
nent. An increase of the entropic component during complex
formation is frequently associated with a conformational
change in a protein molecule that leads to burying hydropho-
bic residues located on the surface of the protein globule (30).
Mg
2+ increases the GTP afﬁnity to the eRF1 eRF3 complex
6-fold (Table 1) in contrast to the eRF3 GDP complex, sug-
gesting that Mg
2+ is implicated in GTP coordination in the
binding site, as shown for other GTP-binding proteins (35).
GTP binding to the eRF1 eRF3 complex is observed only
in phosphate buffer whereas in Tris buffer the signal is too
low to be measured directly.
Nucleotide displacements in the ternary complex
The eRF1-dependent GTPase activity of eRF3 in the ribo-
some (15) implies that the substrate of this reaction should
be a ternary eRF1 eRF3 GTP complex, which has been
described in the previous section. Since the eRF1 eRF3 com-
plex retained its ability to bind GDP, we attempted to dis-
place GDP from the ternary complex by GTP, at 2 mM
Mg
2+. The eRF1 eRF3 complex was saturated with GDP
and then titrated with GTP (Figure 1D). The model of com-
petitive ligand binding (31) was applied. The GTP binding
constant in phosphate buffer, determined by this method, is
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Figure 1. ITC curves (upper panel) and binding isotherms (lower panel) of eRF3 interaction with GDP in the absence (A) or presence of 2 mM (B)o r1 0m M( C)
MgCl2;( D) interaction of the eRF1 eRF3 GDP complex with GTP at 2 mM MgCl2,2 5  C, in phosphate buffer (pH 7.5).
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ing to the eRF1 eRF3 complex (Table 1). As shown in
Figure 1D, GDP displacement by GTP is an endothermic
process. This could be explained by the fact that complex
formation between GTP and the eRF1 eRF3 complex is an
entropically driven process and the enthalpic contribution is
lower than in the case of GDP binding (Table 1). Applying
a competitive ligand binding model we determined the GTP
binding constant (1.8 · 10
6 M
 1) for the eRF1 eRF3 com-
plex in Tris buffer, which appears to be similar to that in
phosphate buffer (Table 1).
By analogy, the ternary eRF1 eRF3 GTP complex was
titrated with GDP (data not shown). In contrast to the GDP/
GTP displacement, the GTP/GDP exchange is an exothermic
process. The GDP association constant in phosphate buffer
determined using the displacement method is similar to the
value determined for GDP binding to the eRF1 eRF3 com-
plex (Table 1). In the absence of eRF1, if the eRF3 GDP
complex was titrated with GTP, no binding was detected as
shown for free eRF3 titrated with GTP.
DISCUSSION
It is becoming clear from recent data in vivo (27) and from
results obtained in a fully reconstituted eukaryotic translation
system (14) that eRF3 ensures a fast and high ﬁdelity transla-
tion termination reaction in contrast to what has been shown
for its prokaryotic analog RF3 (28). This explains why eRF3
is encoded by an essential gene while RF3 is dispensable in
bacterial cells. Here, we measured the thermodynamic
parameters of guanine nucleotide binding to human eRF3,
eRF1 and to the complex of these factors in both phosphate
and Tris buffer. We have shown that (i) eRF3 binds GDP
with a rather weak dependence on Mg
2+ concentration
(Table 1 and Figure 1A–C); (ii) eRF1 and eRF3 bind to
one another irrespective of the presence or absence of gua-
nine nucleotides and of Mg
2+ (Table 1); (iii) the eRF1 eRF3
complex binds both GDP and GTP with a preference for the
latter; (iv) in the eRF1 eRF3 GDP complex, GDP can be
exchanged for GTP (Figure 1D) and vice versa; GDP dis-
placement by GTP proceeds more easily than the reverse
reaction (Table 1).
ITC results compared to earlier data
Our data contradict the results obtained in a yeast system in
which GTP and Mg
2+ are required for complex formation
between eRF1 and eRF3 (29). As shown here, neither GTP
nor GDP is essential for complex formation and binding is
also tolerant to Mg
2+ concentration. One possible reason for
such discrepancies may stem from the fact that eRF1 and
eRF3 were tagged with different proteins (Myc and protein
A) and complex formation was visualized using an indirect
immunoblotting assay (29). Bulky tags may interfere with
eRF1 eRF3 complex formation whereas GTP coordinated
with Mg
2+ can partially weaken this effect. The observation
(29) that mutations in the GTP-binding site of eRF3 impair
the ability of the mutated factor to bind eRF1 is in a sharp
contradiction with other data showing that the eRF1 eRF3
interaction is mediated solely by the C domains of both
factors without involvement of GTP-binding sites (18–20,34).
It has been shown for truncated eRF3 from the ﬁssion yeast
S.pombe that Mg
2+ is not required for GDP binding (24) in
complete agreement with the data obtained here with total
human eRF3 (Table 1 and Figure 1A–C). Our Kd values for
the eRF3 GDP complex (Table 1) are similar to those for
the S.pombe eRF3 GDP measured in the absence of Mg
2+
by the ITC assay. However, at 2.0–2.5 mM Mg
2+, the afﬁnity
of GDP for yeast eRF3 is lost (24). We assume that this
remarkable difference between the data with human eRF3
and that with S.pombe eRF3 may be associated with the
fact that yeast eRF3 was depleted of the N-terminal amino
acid sequence (positions 1–195) and additionally, that the
S.pombe eRF3 differs considerably in amino acid sequence
from human eRF3. A hypothesis (24) that Mg
2+ plays a
role of guanine exchange factor (GEF) with respect to
eRF3 is inconsistent with our observation that eRF3 GDP
complex formation insigniﬁcantly depends on the Mg
2+ con-
centration (Table 1).
For the human eRF3 GDP complex Kd ¼1.9 mMa t2m M
Mg
2+ (Table 1). This is in sharp contrast to the Kd ¼ 5.5 nM
at 5 mM Mg
2+ for the prokaryotic RF3 GDP complex (28).
The three orders of magnitude difference in dissociation con-
stants points to a profound difference between the structure of
the GDP-binding sites of eRF3 and RF3. Since GDP binding
to eRF3 is a one-step process (Table 1 and Figure 1), no con-
formational transformation of eRF3 is required to bind GDP
to the factor. GDP binding to eRF3 is not affected by eRF1
(Table 1) in agreement with the data showing that
eRF1 eRF3 complex formation is mediated by the C-termini
of both factors and does not involve the GTP/GDP-binding
center of eRF3 (18–20,34).
eRF1 as affector of guanine nucleotide binding to eRF3
In mammalian cells, the GTP concentration is one order of
magnitude higher than the GDP concentration (36) and in
yeast cells the eRF1 and eRF3 concentrations are roughly
equal (37). However, the >2 orders of magnitude difference
between the Kd’s for GDP and GTP implies that in vivo in
the absence of eRF1, eRF3 exists predominantly in a GDP-
bound form as shown for bacterial RF3 (28). When eRF3 is
complexed with eRF1, the binary complex possesses higher
afﬁnity for GTP than for GDP (Table 1) and displaces GDP
from the complex, if it has been bound before eRF3. The
most plausible explanation of the effect of eRF1 stems
from the suggestion (17) that in a binary complex either
eRF3 or eRF1 or both factors undergo signiﬁcant conforma-
tional changes. This structural alteration can induce the
appearance of a site in the nucleotide binding center of
eRF3 able to bind the g-phosphate moiety of GTP which is
absent in the eRF3 GDP complex. Therefore, eRF1 does
not disturb GDP binding to eRF3 as shown above but modi-
ﬁes the nucleotide binding center in such a way that GTP
binding becomes more favorable than GDP binding. In
accord with this interpretation, we may speculate that the
function of eRF1 with respect to eRF3 resembles that of a
GAP (GTPase-activating protein).
Surprisingly, the inﬂuence of Mg
2+ on the GDP binding
constant is very weak (Table 1 and Figure 1A–C) implying
that Mg
2+ is not involved in coordination with GDP as
reported for some other GDP/GTP-binding proteins
Nucleic Acids Research, 2006, Vol. 34, No. 14 3951[reviewed in (35)]. Since most GEFs act by distorting the
GDP/GTP-binding site stabilized by Mg
2+ (38), because of
Mg
2+-independence in the case of eRF3, there is no need to
distort the eRF3-binding site. Therefore, the absence of
Mg
2+ effect on eRF3 GDP association suggests that eRF3
does not require a special GEF as do other GTPases (35).
For instance, the translation factors IF2 and EF-G do not
require GEFs in the form of external proteins for GDP/GTP
exchange and the ribosome itself performs this function
toward these factors (39).
Since Mg
2+ increases the afﬁnity of GTP for the
eRF1 eRF3 complex (Table 1) in contrast to GDP binding
to eRF3, Mg
2+ is most likely coordinated in the GTP-binding
site stabilizing the appropriate conformation of the switch 1
and switch 2 elements that are disordered in free eRF3 as
shown by structural analyses (24).
A model of eRF3 interaction with eRF1
and guanine nucleotides
Based on the results described above (Table 1 and Figure 1)
we suggest a sequence of interactions of eRF3 with its ligands
that is consistent with the data available. Routes (a) and (b)
can be considered (Figure 2). If eRF3 follows route (a), it
binds GDP in a Mg
2+-independent manner. Since eRF3
binds GDP but not GTP it seems possible that eRF3 similar
to prokaryotic RF3 (28) is present in the eukaryotic cytosol
in a GDP-bound state. At step Ia, eRF1 binds to the
eRF3 GDP complex and probably changes the conformation
of eRF3. As eRF3 is most likely in a GDP-bound form and
the binding constant for reaction Ia is 3.5 times higher than
for association of eRF3 with eRF1 (step Ib), the ternary
eRF1 eRF3 GDP complex could be formed more easily
than the eRF1 eRF3 complex. GDP in the eRF1 eRF3 GDP
complex would then be displaced by GTP (step IIa). Owing
to conformational changes induced by eRF1 upon binding
as proposed earlier (17), eRF3 could acquire the ability to
bind GTP and to displace GDP. This displacement/exchange
reaction becomes possible not because of decrease of the
eRF3-binding constant to GDP, which is not altered as
shown here (Table 1). Since the constant of GTP binding to
the eRF1 eRF3 complex is four times higher than that to
GDP (Table 1) and the GTP concentration in mammalian
cells is at least 10 times higher than the GDP concentration
(36), this induces the displacement reaction. At physiological
(0.5–2.0 mM) Mg
2+ concentration (40) the afﬁnity of GTP for
eRF1 eRF3 is 6-fold higher than in the absence of Mg
2+.I n
contrast for GDP binding the Mg
2+ effect is absent.
Route (b) is in principle also possible (Figure 2). If eRF3
binds ﬁrst to eRF1 and not to GDP as in route (a), it acquires
the ability to bind directly to GTP (IIb). Although the binding
constant of eRF3 with eRF1 is two times higher than that of
eRF3 with GDP, route (b) appears less likely because the
concentration of eRF1 seems to be lower than that of GDP.
Irrespective of whether the routes (a) or (b) or both take
place, the resulting product is formation of the ternary
eRF1 eRF3 GTP complex. Given that Mg
2+ stabilizes the
ternary complex, we assume that the structure is rather a qua-
ternary complex which includes Mg
2+ coordinated with GTP
and eRF3. Quaternary eRF1 eRF3 GTP Mg
2+ complex
formation can proceed in the cytosol. In view of our results,
the functionally active quaternary complex requires neither
an additional external GEF, nor the GEF activity of the ribo-
some known to catalyze guanine nucleotide exchange in
prokaryotic ribosomes toward translation factor GTPases
(39). If so, the role of the ribosome toward the quaternary
complex is to catalyze GTPase hydrolysis which is entirely
ribosome-dependent (15). Therefore, at termination of trans-
lation not only is the function of eRF3 and RF3 entirely dif-
ferent (14,41) but also it seems likely that the ribosomes in
prokaryotes and eukaryotes are also distinct with regard to
translation termination process.
The present study was carried out in parallel with investi-
gations (42) based on entirely different tools, but dealt with
the same problem. The results appear in most cases similar
although some differences in interpretation exist.
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